ZA986155B - (+)-norcisapride. - Google Patents
(+)-norcisapride.Info
- Publication number
- ZA986155B ZA986155B ZA9806155A ZA986155A ZA986155B ZA 986155 B ZA986155 B ZA 986155B ZA 9806155 A ZA9806155 A ZA 9806155A ZA 986155 A ZA986155 A ZA 986155A ZA 986155 B ZA986155 B ZA 986155B
- Authority
- ZA
- South Africa
- Prior art keywords
- norcisapride
- Prior art date
Links
- ZDLILMQNLSEPLK-UHFFFAOYSA-N 2-chloro-5-methoxy-n-piperidin-4-ylpyrimidin-4-amine Chemical compound COC1=CN=C(Cl)N=C1NC1CCNCC1 ZDLILMQNLSEPLK-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97202161 | 1997-07-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA986155B true ZA986155B (en) | 2000-01-10 |
Family
ID=8228540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9806155A ZA986155B (en) | 1997-07-11 | 1998-07-10 | (+)-norcisapride. |
Country Status (4)
Country | Link |
---|---|
JP (2) | JP4473350B2 (en) |
CN (1) | CN100343249C (en) |
UA (1) | UA63954C2 (en) |
ZA (1) | ZA986155B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4619931A (en) * | 1983-02-28 | 1986-10-28 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles |
CA1292472C (en) * | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
US4788190A (en) * | 1986-12-24 | 1988-11-29 | Schering Corporation | 2,4,4-tri- and 2,2,4,4-tetra substituted-1,3-dioxolane antifungal, antiallergy compounds |
KR100352147B1 (en) * | 1994-01-24 | 2002-11-11 | 얀센 파마슈티카 엔.브이. | Water-soluble azole antifungal agents |
-
1998
- 1998-07-07 JP JP50812999A patent/JP4473350B2/en not_active Expired - Lifetime
- 1998-07-07 UA UA99126609A patent/UA63954C2/en unknown
- 1998-07-07 CN CNB988069830A patent/CN100343249C/en not_active Expired - Lifetime
- 1998-07-10 ZA ZA9806155A patent/ZA986155B/en unknown
-
2010
- 2010-01-04 JP JP2010000239A patent/JP2010132666A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2010132666A (en) | 2010-06-17 |
UA63954C2 (en) | 2004-02-16 |
JP2002508002A (en) | 2002-03-12 |
CN100343249C (en) | 2007-10-17 |
CN1262684A (en) | 2000-08-09 |
JP4473350B2 (en) | 2010-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA9710429B (en) | Broad-spectrumδ-endotoxins. | |
ZA984849B (en) | Compositions. | |
ZA996185B (en) | Sulfanylsilanes. | |
ZA979199B (en) | Aminothiophenecarboxamides. | |
ZA976168B (en) | 3-Ureido-pyridofurans and -pyridothiophenes. | |
HK1016976A1 (en) | Resorcinyl-triazine. | |
ZA200005136B (en) | Dihydropyrimides. | |
ZA977206B (en) | Arylalkanoylpyridazines. | |
ZA978304B (en) | 3-alkyl-3-phenyl-piperidines. | |
ZA991272B (en) | Novel thiobenzamides. | |
ZA981926B (en) | Detergent--package combination. | |
ZA987055B (en) | Substituted 4-benzoylpyrazoles. | |
DE59804842D1 (en) | Aliphatische, emissionsarme, sinterfähige thermoplastische polyurethanformmassen | |
ZA987058B (en) | Substituted 4-benzoylpyrazoles. | |
ZA992443B (en) | Hydroxy-methyl-hexanones. | |
ZA995325B (en) | Methylcyclotetradec-5-en-1-ones. | |
ZA993123B (en) | Trisresorcinyltriazines. | |
HK1017834A1 (en) | Bodyshaper. | |
ZA97572B (en) | 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines. | |
ZA97928B (en) | Novel heteroaryl-oxazolidinones. | |
ZA983705B (en) | Pregnan-3-ol-20-ones. | |
ZA974052B (en) | New benzothiazolinones. | |
ZA987B (en) | Substituted 4-benzoylpyrazoles. | |
ZA976022B (en) | Cycloalkano-pyridines. | |
ZA971466B (en) | Endothelin-receptor-antagonists. |